Medicare Enrolled

Dr. Haris Amin, MD

Retina Specialist (Ophthalmology) Physician · Toms River, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
780 ROUTE 37 W, Toms River, NJ 08755
7327971855
In practice since 2005 (21 years)
NPI: 1013910942 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Amin from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Amin? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Amin

Dr. Haris Amin is a retina specialist physician in Toms River, NJ, with 21 years of NPI registration. Based on federal Medicare data, Dr. Amin performed 24,947 Medicare services across 3,776 unique beneficiaries.

Between the years covered by Open Payments, Dr. Amin received a total of $1,419 from 12 pharmaceutical and/or device companies across 80 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Amin is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 21 years in practice ▲ Top 16% volume in NJ $1,419 industry payments

Medicare Practice Summary

Medicare Utilization ↗
24,947
Medicare services
Top 16% in NJ for retina specialist (ophthalmology) physician
3,776
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,188 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
13,140 $29 $56
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
3,070 $33 $66
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
2,628 $99 $208
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,660 $93 $184
Aflibercept eye injection (Eylea) 1,128 $685 $1,323
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
684 $56 $108
Fluorescein angiography of retina
A special camera captures images of the blood vessels in the retina and the area between the white part of the eye and the retina after a dye is injected.
678 $227 $436
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
581 $117 $230
Fluorescein angiography of the eye
An imaging test of the front part of the eye using a special camera after a dye is injected to visualize blood flow.
398 $125 $244
Injection, ranibizumab, 0.1 mg 349 $178 $343
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
223 $76 $148
Retinal and optic nerve function test
A diagnostic test that measures how well the retina and optic nerve are functioning.
156 $96 $212
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
152 $128 $269
Steroid injection (triamcinolone)
A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered.
80 $1 $2
Injection into eye membrane
A procedure involving the injection of a drug or substance into the membrane that covers the eyeball.
20 $38 $84
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,419
Total received (2018-2024)
Avg $203/year across 7 years
Bottom 32% in NJ for retina specialist (ophthalmology) physician
12
Companies
80
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,419 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$346
2023
$255
2022
$330
2021
$105
2020
$70
2019
$136
2018
$176

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$136
Astellas Pharma US Inc
$127
Genentech USA, Inc.
$66
ABBVIE INC.
$16
Top 3 companies account for 95.4% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Healthcare Solutions, Inc.
$728
Genentech USA, Inc.
$211
Astellas Pharma US Inc
$127
Novartis Pharmaceuticals Corporation
$124
Allergan Inc.
$92
Genentech, Inc.
$33
Alimera Sciences, Inc.
$28
Carl Zeiss Meditec AG
$19
ABBVIE INC.
$16
Mallinckrodt LLC
$14
Bausch & Lomb Americas Inc.
$14
Allergan, Inc.
$12
Top 3 companies account for 75.2% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BROLUCIZUMAB · EYLEA · EYLEA HD · Iluvien · Izervay · Lucentis · None Specified · OZURDEX · VABYSMO · Vabysmo · XIPERE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a retina specialist physician in Toms River?
Compare retina specialist physicians in the Toms River area by procedure volume, costs, and industry payment transparency.
Browse retina specialist physicians nearby

Geographic Context

Retina specialist physicians within 10 mi
5
Per 100K population
0.8
County median income
$86,411
Nearest hospital
COMMUNITY MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Amin is a mixed practice specialist, with above-average Medicare volume (top 16% in NJ), with low-engagement industry engagement, with 21 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Amin experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Amin performed 13,140 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Amin receive payments from pharmaceutical companies?
Yes. Dr. Amin received a total of $1,419 from 12 companies across 80 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Amin's costs compare to other retina specialist physicians in Toms River?
Dr. Amin's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Amin) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →